Evidence map›Paper›PMID 42529171›Full record

ArticleFrontiers in immunology2026

Deoxyguanosine kinase deficiency couples purine metabolism to innate immune activation and lipid accumulation in hepatocytes.

Maija Corey, Mahati Rayadurgam, Mousa Vatanmakanian, Alicia Gibbons, Carolina Altbaum, Jeamin Jung, Neha Reddy, Priyanka Saminathan, Kiyokazu Kakugawa, Sonia Sharma

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maija CoreyCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, United States.
Mahati RayadurgamCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, United States.
Mousa VatanmakanianCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, United States.
Alicia GibbonsCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, United States.
Carolina AltbaumCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, United States.
Jeamin JungCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, United States.
Neha ReddyCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, United States.
Priyanka SaminathanCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, United States.
Kiyokazu KakugawaLaboratory for Inflammatory Immune Metabolism, Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan.
Sonia SharmaCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, United States.

Funding

Eicosanoids, Chronic Kidney Disease Progression, and Associated Cardiovascular RiskR01DK141162 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI Susan Cheng · 2024 to 2026
$3.6M
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer ImmunotherapyR01CA256133 · NCI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI DENNIS, EDWARD A, SHARMA, SONIA · 2021 to 2025
$3.5M
Optimizing immunoradiotherapy for HNSCCR01CA281285 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Joseph A Califano, Andrew B. Sharabi · 2023 to 2026
$2.7M
NCI NIH HHS R01 CA256133NCI NIH HHS R01 CA281285NIDDK NIH HHS R01 DK141162
6 · The paper itself

Abstract

Introduction: Mitochondrial DNA depletion syndromes (MDS) caused by deoxyguanosine kinase (DGUOK) deficiency are classically attributed to impaired mitochondrial DNA (mtDNA) maintenance. However, many patients develop hepatic steatosis and inflammation despite preserved mtDNA content, suggesting that additional pathogenic mechanisms contribute to disease. DGUOK is a key enzyme in the mitochondrial purine salvage pathway, but its role in coordinating purine metabolism with lipid homeostasis and innate immune signaling remains poorly understood. Methods: Acute DGUOK deficiency was induced in human hepatocellular carcinoma (HepG2) hepatocytes by siRNA-mediated knockdown. Mitochondrial integrity was assessed by mtDNA quantification, mitochondrial morphology, and oxidative phosphorylation (OXPHOS) protein expression. Lipid accumulation was evaluated by BODIPY staining, and transcriptomic changes were analyzed by bulk RNA sequencing. Purine imbalance was modeled by treatment of wild-type cells with 2'-deoxyadenosine, followed by assessment of DNA methylation, interferon signaling, and lipid accumulation. Results: Acute DGUOK depletion induced a 2.9-fold increase in intracellular lipid droplet accumulation and activation of a type I interferon (IFN) transcriptional program despite preserved mtDNA copy number, mitochondrial morphology, and OXPHOS complex expression. Bulk RNA sequencing revealed induction of human endogenous retroviruses (HERVs) and interferon-stimulated genes (ISGs), together with suppression of lipid metabolic pathways and remodeling of purine-, methionine-, and methylation-associated networks. Consistent with these transcriptional changes, DGUOK-deficient cells exhibited an approximately 40% reduction in global DNA methylation, accompanied by hypomethylation of CpG-rich region within the Discussion: These findings demonstrate that acute DGUOK deficiency promotes innate immune activation and metabolic reprogramming through a purine-dependent mechanism that precedes mtDNA depletion and overt mitochondrial dysfunction. By linking disrupted mitochondrial purine salvage to HERV and ISG derepression, interferon signaling, epigenetic remodeling, and steatosis, this study provides a mechanistic framework for the immunometabolic pathology of DGUOK deficiency and identifies mitochondrial purine metabolism as an important regulator of hepatic immune and metabolic homeostasis.

Indexed as

HepatocytesImmunity, InnateLipid MetabolismPhosphotransferases (Alcohol Group Acceptor)PurinesDNA, MitochondrialHep G2 CellsHumansInterferon Type IMitochondrial DiseasesOxidative PhosphorylationSignal Transductiondeoxyguanosine kinaseDNA, MitochondrialInterferon Type IPhosphotransferases (Alcohol Group Acceptor)purinePurinesdeoxyguanosine kinase deficiencyhepatic steatosishuman endogenous retroviral elementsimmunometabolismpurine metabolismtype I interferon

Identifiers

PMID42529171
PMCPMC13416635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.